NEW YORK, May 7 – Orchid BioSciences announced today approval from the American Association of Blood Banks to use single nucleotide polymorphisms as stand-alone geneitic markers in its paternity testing operations.

 

Orchid is replacing conventional short tandem repeat technology with its SNP genotyping technology in its paternity testing operations. 

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.